Anti-IL5 therapies for chronic obstructive pulmonary disease (Protocol)

Tim Donovan; Iain Crossingham; Stephen J. Milan; Ran Wang; Patrick Bradley

doi:10.1002/14651858.cd013432

Anti-IL5 therapies for chronic obstructive pulmonary disease (Protocol)

Tim Donovan
, Iain Crossingham
, Stephen J. Milan
, Ran Wang
, Patrick Bradley

University of Cumbria

Research output: Contribution to journal › Journal Article › peer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of monoclonal antibody therapies targeting IL‐5 signalling (anti‐IL‐5 or anti‐IL‐5Rα) compared with placebo in the treatment of adults with COPD.

Original language	English
Pages (from-to)	Art. No.: CD013432
Journal	Cochrane Database of Systematic Reviews
Volume	9
DOIs	https://doi.org/10.1002/14651858.cd013432
Publication status	Published online - 20 Sept 2019

Access to Document

10.1002/14651858.cd013432

Donovan et al-2019-Cochrane Database of Systematic ReviewsOther version, 177 KB

https://doi.org/10.1002/14651858.CD013432

Cite this

@article{830b1aef74134804b1d26ad54a459e06,

title = "Anti-IL5 therapies for chronic obstructive pulmonary disease (Protocol)",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of monoclonal antibody therapies targeting IL‐5 signalling (anti‐IL‐5 or anti‐IL‐5Rα) compared with placebo in the treatment of adults with COPD.",

author = "Tim Donovan and Iain Crossingham and Milan, \{Stephen J.\} and Ran Wang and Patrick Bradley",

note = "See also Anti-IL-5 therapies for chronic obstructive pulmonary disease (Review) https://doi.org/10.1002/14651858.CD013432.pub2 In Insight here: https://insight.cumbria.ac.uk/id/eprint/7371/",

year = "2019",

month = sep,

day = "20",

doi = "10.1002/14651858.cd013432",

language = "English",

volume = "9",

pages = "Art. No.: CD013432",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "Cochrane Collaboration / Wiley",

}

TY - JOUR

T1 - Anti-IL5 therapies for chronic obstructive pulmonary disease (Protocol)

AU - Donovan, Tim

AU - Crossingham, Iain

AU - Milan, Stephen J.

AU - Wang, Ran

AU - Bradley, Patrick

N1 - See also Anti-IL-5 therapies for chronic obstructive pulmonary disease (Review) https://doi.org/10.1002/14651858.CD013432.pub2 In Insight here: https://insight.cumbria.ac.uk/id/eprint/7371/

PY - 2019/9/20

Y1 - 2019/9/20

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of monoclonal antibody therapies targeting IL‐5 signalling (anti‐IL‐5 or anti‐IL‐5Rα) compared with placebo in the treatment of adults with COPD.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of monoclonal antibody therapies targeting IL‐5 signalling (anti‐IL‐5 or anti‐IL‐5Rα) compared with placebo in the treatment of adults with COPD.

U2 - 10.1002/14651858.cd013432

DO - 10.1002/14651858.cd013432

M3 - Journal Article

SN - 1465-1858

VL - 9

SP - Art. No.: CD013432

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

ER -

Anti-IL5 therapies for chronic obstructive pulmonary disease (Protocol)

Abstract

Access to Document

Fingerprint

Cite this